University of California, San Diego
La Jolla, California, 92093, United States
NCT Number: NCT01202175
The investigators aim to evaluate subjects at high risk of future development of hypertension, those with a family history of hypertension and/or that already have high normal(SBP 120-139 mmHg or DBP 80-89 mmHg) blood pressure. The investigators plan to investigate whether these subjects have the same markers (such as microscopic protein in the urine or C-reactive protein in the blood) in the blood and urine that people with high blood pressure have, and whether they are improved before and after taking the beta-blocker nebivolol.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Phase 4
La Jolla, California, 92093, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral nebivolol 2.5-5mg once daily
Other names: Bystolic
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
Time frame: Baseline (visit 1) and 8 Weeks (visit 2)
Time frame: Basline (visit 1) and 8 weeks (visit 2)
University of California, San Diego
Other
Effects of the Novel Beta-adrenergic Antagonist Nebivolol (Bystolic) on Prehypertensive Subjects at Genetic Risk of Hypertension: Implications for Inflammation, Endothelial Dysfunction, and Oxidative Stress.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04275037
Cardiovascular Diseases, Hypertension
Storrs, Connecticut, United States
View Trial DetailsNCT00585832
Cardiovascular Diseases, Hypertension
Cincinnati, Ohio, United States
View Trial DetailsNCT02705911
Cardiovascular Diseases, Healthy
Leuven, Belgium
View Trial DetailsNCT02148458
Behavior, Body Weight
St Louis, Missouri, United States
View Trial Details